LWM
IDXX icon

LeConte Wealth Management’s Idexx Laboratories IDXX Stock Holding History

LeConte Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
487
+37
+8% +$23.7K 0.18% 102
2025
Q4 		$304K Buy
450
+75
+20% +$51.1K 0.2% 82
2025
Q3 		$240K Buy
+375
New +$228K 0.16% 103

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LeConte Wealth Management's IDXX Position: Q1 2026 in Review

LeConte Wealth Management increased its Idexx Laboratories (IDXX) stake by 8.2% in Q1 2026, buying an estimated $23.7K and bringing the position to 487 shares worth $274K. The position accounts for 0.18% of the portfolio, ranked #102.

LeConte Wealth Management first reported a position in IDXX in Q3 2025 and has held it in 3 quarters since. The position peaked at $304K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • LeConte Wealth Management held 487 shares of Idexx Laboratories worth $274K as of Q1 2026.
  • LeConte Wealth Management bought 37 Idexx Laboratories shares in Q1 2026, an estimated $23.7K.
  • Idexx Laboratories made up 0.18% of LeConte Wealth Management's portfolio in Q1 2026, its #102 holding.
  • LeConte Wealth Management first reported a position in Idexx Laboratories in Q3 2025 and has held it in 3 quarters since.
  • LeConte Wealth Management's Idexx Laboratories position peaked at $304K in Q4 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.